Attached files
| file | filename |
|---|---|
| EX-99.2 - Sonnet BioTherapeutics Holdings, Inc. | ex99-2.htm |
| EX-99.1 - Sonnet BioTherapeutics Holdings, Inc. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 1, 2015 (August 31, 2015)
CHANTICLEER HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 000-29507 | 20-2932652 | ||
| (State or other jurisdiction | (Commission | (IRS Employer | ||
| of incorporation) | File Number) | Identification No.) |
7621 Little Avenue, Suite 414
Charlotte, North Carolina 28226
(Address of principal executive offices)
Registrant’s telephone number, including area code: (704) 366-5122
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Items.
On August 31, 2015, Chanticleer Holdings, Inc., a Delaware corporation (“Chanticleer” or the “Company”) issued a press release reminding shareholders that in order to be considered a shareholder of record to participate in Chanticleer’s rights offering, shareholders must own HOTR in their brokerage accounts by 4:00 PM ET on Tuesday, September 1, 2015, which is three trading days before the record date of Friday, September 4, 2015. A copy of the press release is attached to this Form 8-K as Exhibit 99.1.
On September 1, 2015, Chanticleer issued a press release announcing the subscription price for its rights offering of $1.35 per share of common stock. A copy of the press release is attached to this Form 8-K as Exhibit 99.2.
In accordance with General Instruction B.2 of Form 8-K, the information contained in Exhibit 99.1 furnished as an exhibit hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, is not subject to the liabilities of that section, and shall not be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The following are filed as exhibits to this Current Report on Form 8-K:
| Exhibit No. | Description | |
| 99.1 | Chanticleer Holdings, Inc. Press Release dated August 31, 2015. | |
| 99.2 | Chanticleer Holdings, Inc. Press Release dated September 1, 2015. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.
| Chanticleer Holdings, Inc., a Delaware corporation (Registrant) | ||
| Date: September 1, 2015 | By: | /s/ Michael D. Pruitt |
| Name: | Michael D. Pruitt | |
| Title: | Chief Executive Officer | |